News
Team
Projects
First Cohort
Second Cohort
Publications
Resources
Events
RTG-Events
Courses
Jobs
Contact
Immunotherapy
Early versus late response to PD-1-based immunotherapy in metastatic melanoma
Background Immune checkpoint inhibition (ICI) currently is the most effective treatment to induce durable responses in metastatic …
Georg C Lodde
,
Fang Zhao
,
Rudolf Herbst
,
Patrick Terheyden
,
Jochen Utikal
,
Claudia Pföhler
,
Jens Ulrich
,
Alexander Kreuter
,
Peter Mohr
,
Ralf Gutzmer
,
Friedegund Meier
,
Edgar Dippel
,
Michael Weichenthal
,
Philipp Jansen
,
Bernd Kowall
,
Wolfgang Galetzka
,
Fabian Hörst
,
Jens Kleesiek
,
Birte Hellwig
,
Jörg Rahnenführer
,
Luisa Rajcsanyi
,
Triinu Peters
,
Anke Hinney
,
Jan-Malte Placke
,
Antje Sucker
,
Annette Paschen
,
Jürgen C. Becker
,
Elisabeth Livingstone
,
Lisa Zimmer
,
Alpaslan Tasdogan
,
Alexander Roesch
,
Eva Hadaschik
,
Dirk Schadendorf
,
Klaus Griewank
,
Selma Ugurel
Cite
Doi
ScienceDirect
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
Purpose Clinical trials demonstrated significantly improved recurrence-free survival (RFS) of melanoma patients receiving adjuvant …
Georg C Lodde
,
Jessica Hassel
,
Lena M Wulfken
,
Friedegund Meier
,
Peter Mohr
,
Katharina Kähler
,
Axel Hauschild
,
Bastian Schilling
,
Carmen Loquai
,
Carola Berking
,
Svea Hüning
,
Julia Eckardt
,
Ralf Gutzmer
,
Lydia Reinhardt
,
Valerie Glutsch
,
Ulrike Nikfarjam
,
Michael Erdmann
,
Catharina L Beckmann
,
Andreas Stang
,
Bernd Kowall
,
Wolfgang Galetzka
,
Alexander Roesch
,
Selma Ugurel
,
Lisa Zimmer
,
Dirk Schadendorf
,
Andrea Forschner
,
Elisabeth Livingstone
Cite
Doi
ScienceDirect
PubMed
Cite
×